BioRender 图标

LRP-2 (Megalin)

LRP-2 (Megalin) - Editable icon of a megalin or LRP2 receptor with complement-type repeats, EGF-type repeats, YWTD repeats, a transmembrane domain and NPXY motif
[{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c8/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c8/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c7/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c7/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c6/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c6/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c5/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c5/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c4/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c4/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c3/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c3/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c2/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c2/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c1/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c1/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5c0/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c0/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5bf/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bf/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5be/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5be/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5bd/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bd/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5bc/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bc/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5bb/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bb/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5ba/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ba/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b9/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b9/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b8/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b8/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b7/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b7/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b6/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b6/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b5/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b5/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b4/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b4/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b3/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b3/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b2/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b2/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b1/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b1/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5b0/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b0/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5af/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5af/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5ae/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ae/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5ad/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ad/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5ac/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ac/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5ab/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ab/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5aa/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5aa/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a9/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a9/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a8/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a8/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a7/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a7/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a6/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a6/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a5/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a5/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a4/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a4/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a3/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a3/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a2/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a2/5fbd693303051c0027d1f527.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbd6f5503051c0027d1f5a1/5fbd693303051c0027d1f527.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a1/5fbd693303051c0027d1f527.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
megalin,LRP2,low density lipoprotein-related protein 2,EGF type,complement type,YWTD,NPXY,gp330,plasma membrane,endocytosis,endothelial,cubilin,thyroid,LRP2,megalin
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

LRP-2 (Megalin) icon JPEG

LRP-2 (Megalin) icon PNG

LRP-2 (Megalin) icon SVG

LRP-2 (Megalin) icon GIF

BioRender 图标常见问题解答

How are scientists using the LRP-2 (Megalin) icon in their work?

BioRender users often use the LRP-2 (Megalin) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the LRP-2 (Megalin) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the LRP-2 (Megalin) icon customizable in BioRender?

Most icons in BioRender, including the LRP-2 (Megalin) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the LRP-2 (Megalin) icon for publication or presentations?

Yes, figures containing the LRP-2 (Megalin) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the LRP-2 (Megalin) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the LRP-2 (Megalin) icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this LRP-2 (Megalin) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon